1 / 12

AI in Drug Discovery Market to Reach US$ 9,072.2 million by 2030

According to the Market Statsville Group (MSG), the global AI in drug discovery market size is expected to grow from USD 910.7 million in 2021 to USD 9,072.2 million by 2030, at a CAGR of 29.1% from 2022 to 2030. A machine that uses contemporary technology to carry out tasks that are similar to those carried out by the human mind is referred to as having artificial intelligence (AI). Finding drugs that can help prevent or treat particular diseases is the main goal of drug discovery research. The need for artificial intelligence (AI) in the drug discovery industry was fuelled by the challenges

vipin13
Download Presentation

AI in Drug Discovery Market to Reach US$ 9,072.2 million by 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Market Research Report EXCLUSIVE EDITION Global AI in Drug Discovery Market Report Opportunities, and Forecast By 2030 Global Industry Analysis, Forecast and Trends, 2030 © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807

  2. Global AI in Drug Discovery Market © 2020 Statsville Consulting Private Limited Market Statsville Group (MSG) A part of Statsville Consulting Private Limited American Office American Office – 800 Third Avenue Suite A #1519 New York, NY 10022 EMEA EMEA– 1165 Budapest 16 Diósy Lajos u. 24., Europe Asia Asia- -Pacific Office Pacific Office – F-178 Subhash Marg C Scheme, Ashok Nagar, Jaipur, Rajasthan, 302001 www.marketstatsville.com Disclaimer Disclaimer: : Any information and/or material provided by Statsville Consulting Private Limited, including any and all the analysis and/or research from Market Statsville Group (MSG), is offered to a selected group of customers in response to orders for such information, material, analysis, and/or research. As a customer of Statsville Consulting, you acknowledge that our information, material, and/or services are for your internal use only, and not for any external use and/or dissemination, or general publication, and/or disclosure to any third parties. Any and all the information and/or material provided by Statsville Consulting are based on primary interviews and/or secondary research, and are, therefore, subject to fluctuation and variance. Statsville Consulting takes no responsibility for any incorrect information and/or material supplied to us by sources we rely on, and no part of our analysis or research may be given, lent, resold, or disclosed to any third parties, including non-customers, without explicit or written permission from Statsville Consulting. Unauthorized reproduction and/or transmission of our information, material, analysis, and/or research in any form and by any means, including photocopying, mechanical/electronic recording,or otherwise, without the explicit and written permission of Statsville Consulting, is expressly and clearly prohibited. Any use of the information, material, analysis, and/or research provided by Statsville Consulting is at your sole risk; you acknowledge that the information, material, analysis, and/or research is provided “as is” and that Statsville Consulting provides no warranty of any kind, express or implied, with regard to the information, material, analysis, and/or research, including but not limited to, merchantability and fitness for any purpose and/or use. At the end, Statsville Consulting will be responsiblefor the final decision of any action. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807

  3. ABOUT MARKET STATSVILLE GROUP (MSG) Market Statsville Group (MSG) partners with companies and society to confront their essential risks and challenges to capture the enormous opportunities for them. MSG was initiated its working in 2017, and since then, the brand is moving to become a pioneer in business advisory and market research services. Market Statsville is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in the form of market sizing, analysis, and incisive business insights. MSG experienced research analysts are proficient at digging deep and providing a variety of customizable data that help you make decisions with clarity, confidence, and impact. Market Statsville is your global data intelligence partner for reliable market research data, data gathering, and analytical services. MSG also has an extensive network of top-flight domestic and global research personals around the world, enabling us to provide high-quality worldwide research solutions that cater to a well-established company, government organizations, or a startup. MSG's clients have the authority to work directly with one or more of our researchers to gather the most useful data knowledge and analytical plan to formulate it in the actual practice. Market Statsville Group believes that to succeed, companies or individuals must blend digital and human capabilities most efficiently. MSG diverse and experienced global team of business consultants and market researchers will ensure the valuable reports for our clients through digging in-depth market information and functional expertise to continuously spark the changes and real-time valuation of variation in the market/industry. MSG works in a uniquely collaborative model throughout the business process across the globe to assist the client's company with the most accurate information that they are aiming for in the reports. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807

  4. RESEARCH PROCESS Our research is an optimum culmination of secondary and primary research, with the latter playing a major role. We also have an in-house repository and access to a number of external regional and global paid databases to help address specific requirements of our clients. The research process begins with a holistic secondary research, followed by expert interviews. The information gathered is then comprehensively analyzed by our highly experienced in-house research panel © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807

  5. AI in Drug Discovery Market 2022: Industry Size, Regions, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2030 AI in Drug Discovery Market by Offering (Software, Service), by Technology (Machine Learning, Others), by Application (Cardiovascular, Metabolic, Neurodegenerative), by End User (Pharma, Biotech, and CROs), by Region – Global Share and Forecast to 2030 Description According to the Market Statsville Group (MSG), the global AI in drug discovery market size is expected to grow from USD 910.7 million in 2021 to USD 9,072.2 million by 2030, at a CAGR of 29.1% from 2022 to 2030. A machine that uses contemporary technology to carry out tasks that are similar to those carried out by the human mind is referred to as having artificial intelligence (AI). Finding drugs that can help prevent or treat particular diseases is the main goal of drug discovery research. The need for artificial intelligence (AI) in the drug discovery industry was fuelled by the challenges of assessing, acquiring and using data to tackle challenging medical problems. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807

  6. The increasing usage of cloud-based apps and services by pharmaceutical organizations will help AI flourish in the drug discovery business. Pharmaceutical vendors are projected to be key players among the numerous end-users of cloud-based drug discovery platforms, with a high-value share of the worldwide cloud-based drug discovery platform market. According to a worldwide market potential study, prominent software suppliers have already embraced cloud-based drug discovery systems to promote smooth research and development operations. Furthermore, the cloud-based drug discovery platform revolution will increase significantly in the next years, providing stronger prospects for software companies to grow and expand. Request Sample Copy of this Report: https://www.marketstatsville.com/request- sample/AI-in-drug-discovery-market COVID-19 Impact on the Global AI in Drug Discovery Market As many nations fight to manage the deadly virus, quick medication discovery for COVID-19 might be a help. Lockdowns and strong limits on people's movement have had a detrimental impact, including massive losses for firms in the AI in the drug development sector. However, finding a suitable therapy for COVID-19 patients might be beneficial in various ways. A team of researchers from the University of Michigan utilized an AI-powered picture to find over 17 current medications to lower coronavirus infection in cells. Such tools and techniques aid in finding current medications' effectiveness against COVID-19, contributing to AI's expansion in the drug discovery market. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807 6

  7. Global AI in Drug Discovery Market Dynamics Drivers: Increasing patent protection expiration The rising relevance of innovative drug development due to the increasing patent expiration of key medications and the increased outsourcing of formulation development services by most pharmaceutical and biotechnological businesses are significant drivers driving market expansion. Most biopharmaceutical businesses collaborate with outsourcing services in the early stages of drug development to mitigate risk and save time and money as the medicine progresses through the development process. Restraints: AI workforce shortage AI is a complicated system requiring a workforce with certain skill sets to create, manage, and deploy AI systems. Personnel interacting with AI systems should be conversant and aware of technologies such as machine intelligence, deep learning, cognitive computing, image recognition, and other AI technologies. Additionally, integrating AI technology into current systems is a hard endeavor that demands extensive data processing to emulate human brain activity. Even little faults might cause system failure and negatively affect the desired output. The lack of professional standards and qualifications in AI/ML technologies limits AI's growth. Opportunities: Mindful AI's Popularity to Provide Huge Opportunities Mindful AI is quickly becoming an excellent alternative for creating pharmaceuticals in a more human-centric and ethical approach. Mindful AI is an intention-based technique used for producing effective AI-based technology. Pharmaceutical businesses may use conscious AI to learn how rapidly a medicine can be created and how inclusive it is in terms of effectiveness. As a result, the increasing popularity of conscious AI in the pharmaceutical sector will create potential development prospects, propelling the overall AI in the drug discovery market. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807 7

  8. Scope of the Global AI in Drug Discovery Market The study categorizes AI in the drug discovery market based on offering, technology, end user, and application at regional and global levels. Direct Purchase Report: https://www.marketstatsville.com/buy-now/AI-in-drug- discovery-market?opt=2950 By Offering Outlook (Sales, USD Million, 2017-2030) •Software •Services By Technology Outlook (Sales, USD Million, 2017-2030) •Machine Learning • Deep Learning • Supervised Learning • Reinforcement Learning • Unsupervised Learning • Other Machine Learning Technologies •Other Technologies By End User Outlook (Sales, USD Million, 2017-2030) •Pharmaceutical & Biotechnology Companies •Contract Research Organizations •Research Centers and Academic & Government Institutes © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807 8

  9. By Application Outlook (Sales, USD Million, 2017-2030) •Immuno-Oncology •Neurodegenerative Diseases •Cardiovascular Diseases •Metabolic Diseases •Other Applications By Region Outlook (Sales, USD Million, 2017-2030) •North America • US • Canada • Mexico •Europe • Germany • Italy • France • UK • Spain • Poland • Russia • The Netherlands • Norway • Czech Republic • Rest of Europe © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807 9

  10. •Asia Pacific • • • • • • • • • • •South America • Brazil • Argentina • Colombia • Rest of South America •The Middle East & Africa • Saudi Arabia • UAE • South Africa • Northern Africa • Rest of MEA China Japan India South Korea Indonesia Malaysia Thailand Singapore Australia & New Zealand Rest of Asia Pacific © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807 10

  11. Access full Report Description, TOC, Table of Figure, Chart, etc: https://www.marketstatsville.com/table-of-content/AI-in-drug-discovery-market Deep learning accounts for the largest market share by technology Based on the technology, the AI in drug discovery market is divided into machine learning technology and Others. The machine learning technology segment is further sub-segmented into deep, supervised, reinforcement, and unsupervised learning. Deep learning witnessed the highest market share in 2021 due to the consistent management of data, saves time, decreases the likelihood of mistakes in the drug development process, and minimizes the burden for end users, which are some of the important aspects driving the market growth of this segment. North America accounts for the highest CAGR during the forecast period by Region Based on the regions, the global AI in drug discovery market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. North America, being an early adopter of advanced technologies expected to have the highest CAGR. North America is home to several important AI technology suppliers and top startup companies. Other market drivers include the region's well-established pharmaceutical sector, a strong focus on R&D with significant R&D investments, and the strong presence of prominent pharmaceutical firms such as Pfizer (US), Abbott Laboratories (US), and Johnson & Johnson (US). As a result, such market trends are likely to assist North America in dominating the overall market. Request For Report Description: https://www.marketstatsville.com/AI-in-drug- discovery-market © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807 11

  12. Thank You Thank You Market Market Statsville StatsvilleGroup (MSG) Group (MSG) F-178 Subhash Marg C Scheme, Ashok Nagar, Jaipur, Rajasthan, 302001 Phone : +91 702 496 8807 Mail : sales@marketstatsville.com 800 Third Avenue Suite A #1519 New York, NY 10022 Phone : +1 (646) 663-5829 Mail : sales@marketstatsville.com

More Related